Alnylam Pharmaceuticals Inc (ALNY)

Industry Biotechnology


This stock can be held in an Investment ISA and an Investment Account
Sell

$399.92

Buy

$402.10

arrow-up$4.97 (+1.25%)

Prices updated at 19 Dec 2025, 14:33 EST
| Prices minimum 15 mins delay
|
Prices in USD

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
$401.90 - $396.06
$495.55 - $205.87
-
52,322.36m
1,320.13
-
17,465
223.70
1,001,810.59
1.05
129.29m
US02043Q1076
0.30
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.